Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against <i>Clostridioides difficile</i> infection challenge <i>in vivo</i>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against Clostridioides difficile infection challenge in vivo

Published:2023-08-24 Issue:4 Volume:14 Page:71-85
ISSN:2150-5330
Container-title:World Journal of Gastrointestinal Pathophysiology
language:
Short-container-title:World J Gastrointest Pathophysiol

Author:

Murphy Christopher K,O’Donnell Michelle M,Hegarty James W,Schulz Sarah,Hill Colin,Ross R Paul,Rea Mary C,Farquhar Ronald,Chesnel Laurent

Publisher

Baishideng Publishing Group Inc.

Subject

General Mathematics

Reference44 articles.

1. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults

2. What do we know about the diagnostics, treatment and epidemiology of Clostridioides ( Clostridium ) difficile infection in Europe?

3. Burden ofClostridium difficileInfection in the United States

4. Risk Factors Associated With Complications and Mortality in Patients With Clostridium difficile Infection

5. Profound Alterations of Intestinal Microbiota following a Single Dose of Clindamycin Results in Sustained Susceptibility to Clostridium difficile-Induced Colitis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease models;Brain, Behavior, and Immunity;2024-10

2. Bacteriocin diversity, function, discovery and application as antimicrobials;Nature Reviews Microbiology;2024-05-10

3. ADS024, a single-strain live biotherapeutic product of Bacillus velezensis alleviates dextran sulfate-mediated colitis in mice, protects human colonic epithelial cells against apoptosis, and maintains epithelial barrier function;Frontiers in Microbiology;2024-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3